Johansen A, Ek J, Mortensen H B, Pedersen O, Hansen T
Steno Diabetes Center and Hagedorn Research Institute, Niels Steensens Vej 2, DK-2820 Gentofte, Denmark.
J Clin Endocrinol Metab. 2005 Aug;90(8):4607-14. doi: 10.1210/jc.2005-0196. Epub 2005 May 31.
AIMS/HYPOTHESIS: Maturity-onset diabetes of the young (MODY) is a genetically heterogeneous monogenic form of diabetes characterized by an autosomal dominant inheritance, an early clinical onset, and a primary defect in beta-cell function. The aims of the present study were to examine the prevalence and nature of mutations in the three common MODY genes, HNF4A, GCK, and TCF1, in Danish patients with a clinical diagnosis of MODY and to describe metabolic differences in probands with and without mutations in HNF4A, GCK, and TCF1.
Seventy-eight unrelated subjects of Danish Caucasian origin (29 men, 49 women) and their 351 family members were examined. The promotor and coding regions including intron-exon boundaries of HNF4A, GCK, and TCF1 were examined by denaturing HPLC and/or direct sequencing.
We identified 29 different mutations in 38 MODY families. Fifteen of the mutations were novel. The variants segregated with diabetes within the families, and none of the variants were found in 100 normal Danish chromosomes. Our findings suggest a relative prevalence of 3% of MODY1 (two different mutations in two families), 10% of MODY2 (seven in eight), and 36% of MODY3 (21 in 28) among Danish kindred clinically diagnosed as MODY. No significant differences in biochemical and anthropometric measurements were observed at baseline examinations.
Forty-nine percent of the families carried mutations in the three examined MODY genes. Our findings highlight that unidentified MODY genes may play a central role for diabetes characterized by autosomal dominant transmission. Furthermore, baseline measurements of various anthropometric and biochemical variables are not appropriate markers of MODYX.
目的/假设:青年发病的成年型糖尿病(MODY)是一种具有遗传异质性的单基因糖尿病,其特征为常染色体显性遗传、临床发病早以及β细胞功能的原发性缺陷。本研究的目的是检测丹麦临床诊断为MODY的患者中三种常见MODY基因HNF4A、GCK和TCF1的突变发生率及性质,并描述HNF4A、GCK和TCF1有突变和无突变的先证者之间的代谢差异。
对78名丹麦白种人血统的非亲属个体(29名男性,49名女性)及其351名家庭成员进行检测。通过变性高效液相色谱法和/或直接测序检测HNF4A、GCK和TCF1的启动子和编码区,包括内含子-外显子边界。
我们在38个MODY家族中鉴定出29种不同的突变。其中15种突变为新发现的突变。这些变异在家族中与糖尿病共分离,在100条正常丹麦染色体中均未发现这些变异。我们的研究结果表明,在丹麦临床诊断为MODY的家族中,MODY1的相对患病率为3%(两个家族中有两种不同突变),MODY2为10%(八个中有七个),MODY3为36%(28个中有21个)。在基线检查中未观察到生化和人体测量指标的显著差异。
49%的家族在所检测的三种MODY基因中携带突变。我们的研究结果突出表明,未明确的MODY基因可能在以常染色体显性遗传为特征的糖尿病中起核心作用。此外,各种人体测量和生化变量的基线测量并非MODYX的合适标志物。